Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N, Fujiwara Y, Wang X, Ohmoto A, Urasaki T, Hayashi N, Sato Y, Nakano K, Yunokawa M, Ono M, Tomomatsu J, Takahashi S. Fukuda N, et al. Among authors: tomomatsu j. Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3037-3043. doi: 10.1007/s00405-020-06481-y. Epub 2020 Nov 21. Eur Arch Otorhinolaryngol. 2021. PMID: 33219858
Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.
Nakano K, Sato Y, Toshiyasu T, Sato Y, Inagaki L, Tomomatsu J, Sasaki T, Shimbashi W, Fukushima H, Yonekawa H, Mitani H, Kawabata K, Takahashi S. Nakano K, et al. Among authors: tomomatsu j. Mol Clin Oncol. 2016 Feb;4(2):303-309. doi: 10.3892/mco.2015.687. Epub 2015 Nov 25. Mol Clin Oncol. 2016. PMID: 26893880 Free PMC article.
Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer.
Tamura K, Kodaira M, Shimizu C, Yonemori K, Yunokawa M, Shimomura A, Kobayashi T, Nakano K, Tomomatsu J, Ito Y, Tanaka J, Kuriki H, Gu Z, Takahashi S. Tamura K, et al. Among authors: tomomatsu j. Cancer Sci. 2018 May;109(5):1592-1601. doi: 10.1111/cas.13561. Epub 2018 Mar 31. Cancer Sci. 2018. PMID: 29500843 Free PMC article. Clinical Trial.
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.
Doi T, Fujiwara Y, Matsubara N, Tomomatsu J, Iwasa S, Tanaka A, Endo-Tsukude C, Nakagawa S, Takahashi S. Doi T, et al. Among authors: tomomatsu j. Cancer Chemother Pharmacol. 2019 Aug;84(2):393-404. doi: 10.1007/s00280-019-03882-7. Epub 2019 Jun 21. Cancer Chemother Pharmacol. 2019. PMID: 31227862 Free PMC article. Clinical Trial.
Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma.
Kawaguchi K, Nakano K, Urasaki T, Fukuda N, Taira S, Ono M, Tomomatsu J, Nishizawa M, Ae K, Matsumoto S, Takahashi S. Kawaguchi K, et al. Among authors: tomomatsu j. In Vivo. 2019 Sep-Oct;33(5):1609-1614. doi: 10.21873/invivo.11644. In Vivo. 2019. PMID: 31471412 Free PMC article.
52 results